OverviewSuggest Edit

Elanix Biotechnologies develops and commercializes products for acute wound care, dermatological and gynecological applications. The Company develops and markets progenitor cell-based products that are used to regenerate tissue and promote healing in the treatment of burns, and gynecological and dermatological conditions. Its products include GYNrepair, a cream for genital external mucosa, and SKINrepair, a cream for skin that protects against external aggressions. Elanix Biotechnologies is also developing FirstCover, an acute wound care tissue engineering product that is used to provide protection and healing for burns, and trauma and plastic surgery. The Company offers cell technology services as well. 

TypePublic
Founded2012
HQFrankfurt am Main, DE
Websiteelanixbiotechnologies.ch

Locations

Elanix Biotechnologies is headquartered in
Frankfurt am Main, Germany

Location Map

Latest Updates

Employees (est.) (Feb 2019)11(+23%)
Revenue (FY, 2017)€328.1 K(+5171%)
Share Price (Oct 2020)€0.8 (-1%)
Cybersecurity ratingAMore

Elanix Biotechnologies Office Locations

Elanix Biotechnologies has offices in Frankfurt am Main, Epalinges and Nyon
Frankfurt am Main, DE (HQ)
Hanauer Landstraße 291B
Epalinges, CH
Route de la Corniche 3
Nyon, CH
10 Chemin du Joran
Show all (3)

Elanix Biotechnologies Financials and Metrics

Elanix Biotechnologies Revenue

Embed Graph
View revenue for all periods
Elanix Biotechnologies's revenue was reported to be €328.15 k in FY, 2017 which is a 5170.6% increase from the previous period.
EUR

Revenue (FY, 2017)

328.1k

Revenue growth (FY, 2016 - FY, 2017), %

5170.6%

Gross profit (FY, 2017)

170.5k

Gross profit margin (FY, 2017), %

52%

Net income (FY, 2017)

3.8m

EBIT (FY, 2017)

4.4m

Market capitalization (16-Oct-2020)

6.5m

Closing stock price (16-Oct-2020)

0.8

Cash (31-Dec-2017)

212.2k
Elanix Biotechnologies's current market capitalization is €6.5 m.
EURFY, 2016FY, 2017

Revenue

6.2k328.1k

Revenue growth, %

5171%

Cost of goods sold

3.5k157.6k

Gross profit

2.7k170.5k
EURFY, 2016FY, 2017

Cash

73.6k212.2k

Accounts Receivable

140.0201.5k

Inventories

33.5k138.7k

Current Assets

177.6k1.3m
EURFY, 2016FY, 2017

Cash From Operating Activities

(823.9k)(3.8m)

Purchases of PP&E

(19.0k)(35.3k)

Cash From Investing Activities

(131.5k)(35.3k)

Long-term Borrowings

(597.4k)(767.7k)
EURFY, 2016

Revenue/Employee

1.2k

Financial Leverage

1.4 x
Show all financial metrics

Elanix Biotechnologies Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Elanix Biotechnologies Revenue Breakdown

Embed Graph

Elanix Biotechnologies revenue breakdown by business segment: 79.6% from Selling Products and 20.4% from Licences

Elanix Biotechnologies Online and Social Media Presence

Embed Graph

Elanix Biotechnologies Blogs

Elanix Biotechnologies Frequently Asked Questions

  • When was Elanix Biotechnologies founded?

    Elanix Biotechnologies was founded in 2012.

  • How many employees does Elanix Biotechnologies have?

    Elanix Biotechnologies has 11 employees.

  • What is Elanix Biotechnologies revenue?

    Latest Elanix Biotechnologies annual revenue is €328.1 k.

  • What is Elanix Biotechnologies revenue per employee?

    Latest Elanix Biotechnologies revenue per employee is €29.8 k.

  • Who are Elanix Biotechnologies competitors?

    Competitors of Elanix Biotechnologies include E-Qure, InspireMD and Soligenix.

  • Where is Elanix Biotechnologies headquarters?

    Elanix Biotechnologies headquarters is located at Hanauer Landstraße 291B, Frankfurt am Main.

  • Where are Elanix Biotechnologies offices?

    Elanix Biotechnologies has offices in Frankfurt am Main, Epalinges and Nyon.

  • How many offices does Elanix Biotechnologies have?

    Elanix Biotechnologies has 3 offices.